Fig. 4From: Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospitalKaplan-Meier survival curve (n = 28). There were initially 28 subjects at the beginning of the study. Of those, 13 were censored for loss to follow-up before 12 months. There were 6 subjects that were surgical failuresBack to article page